Modifying Standard Dose of PRP for Long-term Clinical Outcome of MSK Pathologies

Currently, platelet-rich plasma (PRP) stands as a widely adopted treatment for musculoskeletal issues.Despite promising outcomes linked to PRP application in these conditions, crucial questions persist, such as definitive proof of its effectiveness in altering structures, establishing standard dosages, and devising optimal manual preparation methods to yield high-quality PRP.This review focuses on four key topics regarding the use of PRP in managing musculoskeletal ailments: (a) exploring PRP's composition and its significance, (b) assessing evidence supporting its effectiveness in treating injuries to tendons, joints, ligaments, and muscles, (c) comparing available PRP kits to gauge their cell count variations, and (d) emphasizing the importance of optimizing PRP dosage and its connection to both structural and physiological efficacy on an individual basis.